Meningococcal polysaccharide Group W-135 Vaccine

Specification

• Cat#: H5N1-318
• Product Name: Meningococcal polysaccharide Group W-135 Vaccine
• Description: Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.
• Species: M. polysaccharide

Q&As (1)

Our customer is curious if H5N1-318 (Meningococcal polysaccharide Group W-135 Vaccine Antigen) is a purified polysaccharide and if you have preparation instructions. 5/1/2025

H5N1-318 (Meningococcal polysaccharide Group W-135 Vaccine Antigen) is a purified polysaccharide. No preparation instructions. Each 0.5 mL of H5N1-318 contains 10 microgram each of meningococcal A, C, W, and Y polysaccharide antigens conjugated to approximately 55 micrograms tetanus toxoid protein carrier; 3.35 mg sodium chloride (0.67%), and 1.23 mg sodium acetate (30 mM).